MedTrace Logo

Assisted Rehabilitation Care During Post-stroke mANaGement: fEasibiLity Assessment

NCT03787433 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-06-16

No results posted yet for this study

Summary

The ARCANGEL study evaluates the feasibility of introducing ARC (Assisted Rehabilitation Care), a new device for home-based post-stroke rehabilitation in the current clinical practise. All the stroke survivors included in the study will received their own equipment to be used at home for 6 months.

Conditions

Interventions

DEVICE

ARC - Assisted Rehabilitation Care

ARC is a platform based on wearable inertial sensors and machine learning algorithms, designed to bring the rehabilitation at post-stroke patients' home, following hospital discharge. The product has been created with the purpose to improve physical skills and patient independence accordingly, in the six months following the acute event. ARC aims to optimize, ease and make more accessible the path of post-stroke rehabilitation during post-acute phase, in real life settings.

Sponsors & Collaborators

  • Northern Health and Social Care Trust

    collaborator OTHER_GOV

  • Azienda Sanitaria Locale 3, Torino

    collaborator OTHER

  • Camlin Ltd

    lead INDUSTRY

Principal Investigators

  • Frances Johnston, MSc · Northern Health and Social Care Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-23
Primary Completion
2020-06-12
Completion
2020-06-12

Countries

  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03787433 on ClinicalTrials.gov